372 related articles for article (PubMed ID: 9398667)
1. alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells.
Rusnati M; Tanghetti E; Dell'Era P; Gualandris A; Presta M
Mol Biol Cell; 1997 Dec; 8(12):2449-61. PubMed ID: 9398667
[TBL] [Abstract][Full Text] [Related]
2. A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells.
Rusnati M; Dell'Era P; Urbinati C; Tanghetti E; Massardi ML; Nagamine Y; Monti E; Presta M
Mol Biol Cell; 1996 Mar; 7(3):369-81. PubMed ID: 8868466
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-dependent human vascular smooth muscle cell adhesion requires selective vitronectin phosphorylation by ectoprotein kinase CK2.
Stepanova V; Jerke U; Sagach V; Lindschau C; Dietz R; Haller H; Dumler I
J Biol Chem; 2002 Mar; 277(12):10265-72. PubMed ID: 11756447
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts.
Tanghetti E; Ria R; Dell'Era P; Urbinati C; Rusnati M; Ennas MG; Presta M
Oncogene; 2002 May; 21(24):3889-97. PubMed ID: 12032827
[TBL] [Abstract][Full Text] [Related]
5. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
[TBL] [Abstract][Full Text] [Related]
6. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.
Rusnati M; Tanghetti E; Urbinati C; Tulipano G; Marchesini S; Ziche M; Presta M
Mol Biol Cell; 1999 Feb; 10(2):313-27. PubMed ID: 9950679
[TBL] [Abstract][Full Text] [Related]
7. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.
Kroon ME; Koolwijk P; van der Vecht B; van Hinsbergh VW
Blood; 2000 Oct; 96(8):2775-83. PubMed ID: 11023511
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
9. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
[TBL] [Abstract][Full Text] [Related]
10. Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors.
Wilcox-Adelman SA; Wilkins-Port CE; McKeown-Longo PJ
Cell Adhes Commun; 2000; 7(6):477-90. PubMed ID: 11051458
[TBL] [Abstract][Full Text] [Related]
11. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
[TBL] [Abstract][Full Text] [Related]
13. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
14. T-cell factor-4-dependent up-regulation of fibronectin is involved in fibroblast growth factor-2-induced tube formation by endothelial cells.
Kanda S; Miyata Y; Kanetake H
J Cell Biochem; 2005 Mar; 94(4):835-47. PubMed ID: 15578569
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of FGF-2-mediated chemotaxis of murine brain capillary endothelial cells by cyclic RGDfV peptide through blocking the redistribution of c-Src into focal adhesions.
Shono T; Mochizuki Y; Kanetake H; Kanda S
Exp Cell Res; 2001 Aug; 268(2):169-78. PubMed ID: 11478843
[TBL] [Abstract][Full Text] [Related]
16. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT
Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells.
Richard C; Liuzzo JP; Moscatelli D
J Biol Chem; 1995 Oct; 270(41):24188-96. PubMed ID: 7592623
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice.
Kuzuya M; Satake S; Ramos MA; Kanda S; Koike T; Yoshino K; Ikeda S; Iguchi A
Exp Cell Res; 1999 May; 248(2):498-508. PubMed ID: 10222141
[TBL] [Abstract][Full Text] [Related]
19. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
Mignatti P; Mazzieri R; Rifkin DB
J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
[TBL] [Abstract][Full Text] [Related]
20. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.
Barillari G; Sgadari C; Fiorelli V; Samaniego F; Colombini S; Manzari V; Modesti A; Nair BC; Cafaro A; Stürzl M; Ensoli B
Blood; 1999 Jul; 94(2):663-72. PubMed ID: 10397733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
